Ken Griffin Zoetis Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 384,100 shares of ZTS stock, worth $74.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

384,100

Previous 180,700 112.56%

Holding current value

$74.2 Million

Previous $30.6 Million 117.78%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $221 Million - $272 Million	-1,518,279 Reduced 85.32%	261,279 $45.3 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $284 Million - $343 Million	1,717,026 Added 2745.84%	1,779,558 $301 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $5.57 Million - $7.36 Million	36,801 Added 143.02%	62,532 $12.3 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $4.1 Million - $4.73 Million	24,559 Added 2095.48%	25,731 $4.48 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $57.8 Million - $66.9 Million	-359,138 Reduced 99.67%	1,172 $201,000
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $71.6 Million - $86.2 Million	-492,325 Reduced 57.74%	360,310 $60 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $71.4 Million - $85.7 Million	544,348 Added 176.57%	852,635 $125 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $50.3 Million - $61.9 Million	-338,971 Reduced 52.37%	308,287 $45.7 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $25.6 Million - $32.9 Million	164,328 Added 34.03%	647,258 $111 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $26.1 Million - $33.7 Million	144,020 Added 42.5%	482,930 $91.1 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $3.86 Million - $4.92 Million	19,908 Added 6.24%	338,910 $82.7 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $24.1 Million - $26.7 Million	-127,441 Reduced 28.55%	319,002 $61.9 Million
Q2 2021 Aug 16, 2021	SELL	$155.9 - $187.99 $67.7 Million - $81.6 Million	-434,039 Reduced 49.3%	446,443 $83.2 Million
Q1 2021 May 17, 2021	BUY	$144.0 - $169.39 $81.9 Million - $96.4 Million	569,015 Added 182.69%	880,482 $139 Million
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $79.4 Million - $88.2 Million	-505,742 Reduced 61.89%	311,467 $51.5 Million
Q3 2020 Nov 16, 2020	BUY	$137.1 - $165.37 $32.2 Million - $38.9 Million	235,112 Added 40.39%	817,209 $135 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $8.19 Million - $10.4 Million	-73,195 Reduced 11.17%	582,097 $79.8 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $3.21 Million - $5.03 Million	-34,689 Reduced 5.03%	655,292 $77.1 Million
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $76.8 Million - $88 Million	-660,369 Reduced 48.9%	689,981 $91.3 Million
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $61.9 Million - $70.6 Million	549,455 Added 68.61%	1,350,350 $168 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $27.8 Million - $32.5 Million	-284,198 Reduced 26.19%	800,895 $90.9 Million
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $49 Million - $60.5 Million	601,156 Added 124.22%	1,085,093 $0
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $4.44 Million - $5.34 Million	-56,028 Reduced 10.38%	483,937 $41.4 Million
Q3 2018 Nov 13, 2018	BUY	$83.5 - $93.23 $18.4 Million - $20.6 Million	220,861 Added 69.21%	539,965 $0
Q2 2018 Aug 10, 2018	BUY	$79.9 - $89.2 $7.55 Million - $8.43 Million	94,512 Added 42.08%	319,104 $0
Q1 2018 May 11, 2018	BUY	$71.51 - $84.69 $11.5 Million - $13.7 Million	161,367 Added 255.23%	224,592 $18.8 Million
Q4 2017 Feb 09, 2018	SELL	$63.24 - $72.8 $2.74 Million - $3.15 Million	-43,287 Reduced 40.64%	63,225 $4.56 Million
Q3 2017 Nov 09, 2017	BUY	$59.73 - $65.4 $6.36 Million - $6.97 Million	106,512	106,512 $6.79 Million

Others Institutions Holding ZTS

# of Institutions

1,897

Shares Held

423M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $90.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account